Dr Jeremy Whelan
Consultant Medical Oncologist
University College Hospital London
1st Floor Central
250 Euston Road
London NW1 2PG

Tel: +44 (0)207 380 9346
Fax: +44 (0)207 380 6999
email: jeremy.whelan@uclh.nhs.uk

Research into Bone and Soft Tissue Tumours

Cancers that arise in bone or soft tissue such as muscle or fat are rare when compared with diseases such as breast, lung or bowel cancer.  Sarcoma is the term commonly applied to this family of tumours.  There are several different types, many of which are most often but not exclusively seen in teenagers and young adults.  These tumours require specialist management involving surgeons and oncologists working very closely together.  While there is no doubt that many patients with these types of cancer may be cured, improvements in treatment are urgently needed.

Because of the rarity of sarcomas and the expertise that is required to successfully look after them, comprehensive treatment is only available in a few centres.  The Middlesex Hospital in close alliance with the Royal National Orthopaedic Hospital at Stanmore have for many years developed an unrivalled experience.  Complex surgery is frequently required and this is carried out on a regular basis.  There is close co-operation between surgeons, oncologists, pathologists, nurses and many other disciplines.  Because of the frequency of bone sarcomas in teenagers we also have a unique in-patient facility at the Middlesex Hospital, the Teenage Cancer Trust Unit.

Alongside the clinical service is an extensive programme of research.  Many patients require chemotherapy and are treated in clinical trials which often are run in conjunction with other similar centres in Europe.  Exploration of new strategies for treatment and new drugs continues to be our focus, as are new methods to be used in surgery to try to minimise the impact on limb function of some of these diseases.   There is now a burgeoning programme of laboratory research looking into the causes of sarcomas and particularly into the causes of treatment failure.

Members of the department work in close collaboration with colleagues in Europe and the rest of world.  This international collaboration is essential if results of treatment are to improve.

For further information please contact: Dr Jeremy Whelan

Donations to the Tom Basker Fund should be made payable to “The Tom Basker Fund, UCL Hospitals Charities (a/c 0412)”. The Fund is administered by University College London Hospitals Charities (Registered Charity Number 229771)."

 

THE LONDON BONE AND SOFT TISSUE TUMOUR SERVICE

A SUPRAREGIONAL MUSCULOSKELETAL ONCOLOGY SERVICE

back